Bernstein Liebhard LLP is a leader in litigating cases involving dangerous drugs, defective medical devices and consumer products. Our user-friendly website is an information and resource center for individuals and their families seeking assistance with their litigation needs.

Featured Cases

Latest News More News
Risperdal Lawsuit Settlement Reported in Pennsylvania Gynecomastia Case
A Pennsylvania Risperdal lawsuit has reportedly been settled for an undisclosed amount. According to The Legal Intelligencer, the gynecomastia case had been scheduled to go to trial on May 9th in the Philadelphia Court of […] ...
FDA Issues New Guidelines for Levaquin, Other Fluoroquinolone Antibiotics
The U.S. Food & Drug Administration (FDA) has issued new guidelines for the use of Levaquin and other fluoroquinolone antibiotics. In a Drug Safety Communication issued on May 12th, the agency advised that fluoroquinolones should […] ...
Xarelto Bleeding Claims Continue, as Federal Litigation Surpasses 4,500 Filings
Xarelto bleeding claims continue to mount in the federal multidistrict litigation now underway in the U.S. district Court, Eastern District of Louisiana. According to court documents, more than 4,500 cases were pending in the proceeding […] ...
Testosterone Lawsuit Court Extends AndroGel Trial Schedule
The federal court overseeing thousands of testosterone treatment lawsuits has decided to extend the litigation’s AndroGel bellwether trial schedule by six weeks. The first cases will likely begin going before juries in the summer of […] ...

A Nationwide Law Practice

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products.  The Firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country for thirteen years.

Our trial attorneys have handled hundreds of cases on behalf of injured consumers and shareholders, recovering over $3.5 billion for our clients.  We have achieved this level of success for our clients by bringing together a unique array of talent.  Our ranks include former attorneys with prominent national law firms, former prosecutors, former regulatory attorneys, former U.S. Circuit Court of Appeals law clerks, former U.S. district court law clerks, in-house investigators, and other expert staff.  In short, when we face off against large corporations, their attorneys and their insurance companies know that we are experienced, trial ready and go the extra mile to bring home wins for our clients.  And our clients rest assured that their rights are being protected by highly experienced counsel.

Among other claims currently being investigated and evaluated by the Firm, which involve a widely array of dangerous drugs, medical devices and consumer products on the U.S. market, our attorneys are actively pursuing testosterone lawsuit claims on behalf of individuals who may have been injured by one of several “Low T” treatment therapies.  These hormone-raising medications may be associated with the risk for heart attacks, strokes and other serious cardiovascular side effects.